Vaccine play: “Four vaccine candidates developed from VXRT's proprietary VAAST platform were assessed in mouse models and elicited a strong immune response.” (finance.yahoo.com/ne...-says-200653838.html)
- Potential upcoming catalyst of a Phase 1 trial
As of last week, down 73% since the yearly high, has begun to reverse.
Very oversold on SlowStoch and has been for nearly a month
Below 100day SMA, only slightly above 200day SMA
Trade closed: target reached:
Even as a late add this was a big winner.
Trade active:
Re-entered, but chasing slightly. Hoping for a break to 9.47 and above.